NWPF

News Archives

Filtered by: June 2005

Stories needed to aid Parkinson’s research

Thursday June 30, 2005

Your story could be the key to finding a cure. The "Don’t Be Silent: Tell Us Your Story" initiative is the first nationwide effort to compile data on Parkinson’s disease from people who have the disorder, which affects the central nervous system.

Read Article

Parkinson’s patient participation needed

Thursday June 30, 2005

"Less than 1 percent of people with Parkinson’s are currently participating in clinical research," said Ben Kirby, communications director of the Parkinson’s Action Network. "That’s just not enough; we need more people to get involved."

Read Article

New Movement in Parkinson’s

Thursday June 30, 2005

Parkinson’s disease, first described in the early 1800s by British physician James Parkinson as "shaking palsy," is among the most prevalent neurological disorders.

Read Article

Michael J. Fox and Parkinson’s Disease

Thursday June 30, 2005

Between one and one-and-a-half million Americans are affected by Parkinson’s disease, a disorder of the central nervous system. "Parkinson’s" is the overall term for at least six different categoriesof the disorder, which usually affects people age 50 or older.

Read Article

Teva and Lundbeck Announce That Azilect (Rasagiline) for Parkinson’s Disease is Now Available in the United Kingdom; Additi

Thursday June 30, 2005

Teva Pharmaceutical Industries Ltd. (Teva) (NASDAQ: TEVA) and H. Lundbeck A/S (Lundbeck) (CSE: LUN) announced today that Azilect(R), a once-daily treatment for Parkinson’s disease (PD) both as monotherapy in patients with early PD and as an adjunct treatment in moderate to advanced disease, is now available in the United Kingdom.

Read Article

Living Large With Parkinson’s

Thursday June 23, 2005

When I was diagnosed with Parkinson’s disease, I had little knowledge of what lay ahead. Most people share that ignorance. Though the reactions of the few I told about my condition were typically intense, with exclamations of great pity or sorrow, this was often followed by a very honest "What exactly is Parkinson’s?"

Read Article

Majority of Physicians Who Treat Parkinson’s Do Not Refer Patients to Clinical Trials, According to National Survey

Thursday June 23, 2005

While almost all (more than 96 percent) of the physicians (i) in the United States who treat people with Parkinson’s agree that clinical trials are necessary to find better treatments for the disease, the majority of physicians have discussed clinical trials with just 10 percent or less of their patients with Parkinson’s disease (65 percent of neurologists and 54 percent of primary care physicians/gerontologists) and have never referred a patient to a clinical trial (53 percent of neurologists and 83 percent of primary care physicians /gerontologists). These are among the highlights of a recent nationwide survey commissioned by The Michael J. Fox Foundation for Parkinson’s Research and conducted by Harris Interactive(R) on behalf of the Advancing Parkinson’s Therapies (APT) campaign.

Read Article

Faulty enzyme sparks Parkinson’s disease

Thursday June 23, 2005

Parkinson’s disease is caused by a faulty enzyme that causes brain proteins to clump -- much like Alzheimer’s or Huntington’s disease, Texas researchers say.

Read Article

Stem cell pioneer does a reality check

Thursday June 23, 2005

In a wide-ranging interview, the man who first cultured human embryonic stem cells talks about the science and the morality surrounding his research.

Read Article

Parkinson Association of the Carolinas Event Schedule

Wednesday June 22, 2005

This summer, the Parkinson’s Association of the Carolinas will be hosting many educational symposia. Here is a schedule of events and a list of the speakers and topics.

Read Article
<< Back 1 - 10 of 37 Next >>

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement